NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index.
The underlying index is a subset of the Morningstar®U. S.
Market IndexSM, which is a broad market index that represents approximately 97% of the market capitalization of publicly-tradedU. S. stocks.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
UCBI | United Community Banks Inc | Financial Services | Banks - Regional | 1000.00% |
JPM | JPMorgan Chase & Co | Financial Services | Banks - Diversified | 3.21% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.03% |
AVGO | Broadcom Inc | Technology | Semiconductors | 2.87% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 2.82% |
XOM | Exxon Mobil Corp | Energy | Oil & Gas Integrated | 2.81% |
AAPL | Apple Inc | Technology | Consumer Electronics | 2.81% |
MSFT | Microsoft Corporation | Technology | Software - Infrastructure | 2.74% |
CVX | Chevron Corp | Energy | Oil & Gas Integrated | 2.67% |
PG | Procter & Gamble Company | Consumer Defensive | Household & Personal Products | 2.25% |
HD | Home Depot Inc | Consumer Cyclical | Home Improvement Retail | 2.13% |
KO | The Coca-Cola Company | Consumer Defensive | Beverages - Non-Alcoholic | 2.03% |
UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.92% |
BAC | Bank of America Corp | Financial Services | Banks - Diversified | 1.72% |
CSCO | Cisco Systems Inc | Technology | Communication Equipment | 1.71% |
IBM | International Business Machines | Technology | Information Technology Services | 1.71% |
PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 1.66% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.58% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 1.34% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.25% |